Arcturus Therapeutics Holdings Inc.

US$10.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARCTHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR 1.81%
Div yield —
ROE (44.37%)
Biotechnology
Beta (5Y) 2.61
PE TTM —
TSR TTM 3.81%
Mkt cap US$298.3M
ROIC (27.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
7.05%
(65.57%)
Hold 9|10|8|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.14
0.16
0.16
12.32%
11.97%
18.31%
18.26%
Revenue$M
31.33
30.88
30.95
31.88
5.80%
(1.21%)
(1.62%)
(0.78%)
Peers (US$298.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.379
0.011
0.010
EBIT/Intx
2.355
0.223
0.181
Own earn%
(304.41)
(1.17)
(4.28)
Sh yield%
36.89
37.66
41.62
Owners
Insiders/Inst%
10.48
67.22
Short interest%
3.23
SBC / revenue%
3.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
9–18
$1 testx
—
Incr. ROIC%
76